In this article, the relationship between the government and business in the Russian pharmaceutical industry is explored. They are working together under a public-private partnership to improve healthcare services and increase access to medicines. This partnership allows the government and businesses to combine their skills and money to run programs and projects that benefit society. The researchers found that this type of collaboration has great potential to enhance the pharmaceutical sector, modernize healthcare, and make medicine more accessible. By partnering up, they can boost competitiveness in the industry and upgrade the overall quality of healthcare services in the country.